Imperial College London

ProfessorPeterSever

Faculty of MedicineNational Heart & Lung Institute

Professor of Clinical Pharmacology & Therapeutics
 
 
 
//

Contact

 

+44 (0)20 7594 1099p.sever

 
 
//

Assistant

 

Mrs Yvonne Green +44 (0)20 7594 1100

 
//

Location

 

333ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Deedwania:2021:10.1001/jamacardio.2020.3151,
author = {Deedwania, P and Murphy, SA and Scheen, A and Badariene, J and Pineda, AL and Honarpour, N and Keech, AC and Sever, PS and Pedersen, TR and Sabatine, MS and Giugliano, RP},
doi = {10.1001/jamacardio.2020.3151},
journal = {JAMA CARDIOLOGY},
pages = {139--147},
title = {Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy Secondary Analysis From the FOURIER Randomized Clinical Trial},
url = {http://dx.doi.org/10.1001/jamacardio.2020.3151},
volume = {6},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Deedwania,P
AU - Murphy,SA
AU - Scheen,A
AU - Badariene,J
AU - Pineda,AL
AU - Honarpour,N
AU - Keech,AC
AU - Sever,PS
AU - Pedersen,TR
AU - Sabatine,MS
AU - Giugliano,RP
DO - 10.1001/jamacardio.2020.3151
EP - 147
PY - 2021///
SN - 2380-6583
SP - 139
TI - Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy Secondary Analysis From the FOURIER Randomized Clinical Trial
T2 - JAMA CARDIOLOGY
UR - http://dx.doi.org/10.1001/jamacardio.2020.3151
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000617276200003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 6
ER -